Nihon Kohden Corporation
Sectors
Pharma & Medical, R&D Facilities
Where it builds
Gunma, Saitama, Tokyo
Stage
3 planned
| Posted | Project | Sector | Location | Investment | Phase |
|---|---|---|---|---|---|
| 2026.08.05 | Nihon Kohden plans production equipment and mold investment at Tomioka facilityNihon Kohden plans to invest ¥530 million in production equipment and molds at a leased facility in Tomioka, Gunma. The disclosure does not specify the construction schedule or additional production capacity. | Pharma & Medical | Tomioka, Gunma | ¥530M | Planned |
| 2026.08.05 | Nihon Kohden plans R&D and other facility investments in TokorozawaNihon Kohden plans to invest in research and development equipment and other facilities at its Comprehensive Technology Development Center and other sites in Tokorozawa, Saitama. The filing discloses a total planned investment of JPY 2.412 billion, but does not specify the construction schedule or incremental capacity. | R&D Facilities | Tokorozawa, Saitama | ¥2.4B | Planned |
| 2026.08.05 | Nihon Kohden to invest in additional equipment at Tokyo headquartersNihon Kohden plans to invest ¥354 million in additional equipment at its headquarters in Shinjuku, Tokyo. The project is scheduled to start in April 2026 and finish in March 2027, funded internally; the disclosure does not specify the equipment or capacity increase. | Pharma & Medical | Shinjuku, Tokyo | ¥354M | Planned |
- Mitsui Fudosan2 projects · ¥600B
- Daiichi Sankyo Europe GmbH3 projects · ¥167.8B
- Daiichi Sankyo4 projects · ¥133B
- Idemitsu Kosan Co., Ltd.3 projects · ¥131.5B
- SKY Perfect JSAT Corporation4 projects · ¥112B
- Sekisui Chemical Co., Ltd.4 projects · ¥96.3B
Browse the sector: Pharma & Medical, R&D Facilities.